PAVmed
PAVM
20 hedge funds and large institutions have $2.03M invested in PAVmed in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 8 reducing their positions, and 6 closing their positions.
0.03% more ownership
Funds ownership: 0.31% → 0.35% (+0.03%)
13% less funds holding
Funds holding: 23 → 20 (-3)
35% less capital invested
Capital invested by funds: $3.1M → $2.03M (-$1.07M)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
63% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$567K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.9K |
| 3 |
SSG
Summit Securities Group
New York
|
+$9.07K |
| 4 |
Morgan Stanley
New York
|
+$6.43K |
| 5 |
CIBC Private Wealth Group
Atlanta,
Georgia
|
+$2.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$93K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$24.8K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$10.8K |
| 4 |
GWS
Glassman Wealth Services
Vienna,
Virginia
|
-$9.55K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$5.22K |
PAVM Hedge Fund Activity: Q1 2024 in Review
20 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2024, worth a combined $2.03M — down 35% from $3.1M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of PAVM and 3 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 3 added.
The largest buyer was First Manhattan, adding an estimated $567K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $93K sold.
- 20 institutional investors held PAVmed (PAVM) as of Q1 2024, down from 23 in Q4 2023.
- Funds reported $2.03M of PAVmed stock for Q1 2024, down 35% quarter-over-quarter.
- 3 funds opened new PAVmed positions in Q1 2024 and 6 closed out, a net change of -3 holders.
- The largest PAVmed buyer in Q1 2024 was First Manhattan, an estimated $567K added.
- The largest PAVmed seller in Q1 2024 was Susquehanna International Group, an estimated $93K sold.
Based on aggregated 13F filings for Q1 2024.